^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    EVX-01

    i
    Company:
    Evaxion
    Drug class:
    Immunostimulant
    Related drugs:
    Apply
    A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma (KEYNOTE-D36) (NCT05309421)
    Phase 2
    Evaxion Biotech A/S
    Recruiting
    Last update posted :
    09/27/2023
    Initiation :
    08/30/2022
    Primary completion :
    06/28/2025
    Completion :
    07/25/2025
    BRAF • CD8 • CD4
    |
    BRAF V600E • BRAF V600
    |
    Keytruda (pembrolizumab) • EVX-01